Clinical Trials Browser

Phase 1 × NETWORK × temsirolimus × Clear all

NCT02343718 2023-08-04

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Phase 1 Completed

Lymphoma

NCT00788580 2015-03-06

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific